Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CMND
CMND
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CMND News
Clearmind Files Patent Application in India for Next-Gen Psychedelic Compounds
3d ago
Newsfilter
Clearmind Unveils Patent for Innovative Weight Loss Therapy
Mar 10 2026
Yahoo Finance
Clearmind's CMND-100 Clinical Trial Receives Approval
Mar 04 2026
Newsfilter
Clearmind's MEAI Drug Breakthrough in Obesity Treatment
Feb 19 2026
PRnewswire
Clearmind's MEAI Drug Breakthrough in Obesity Treatment
Feb 19 2026
Newsfilter
Clearmind Medicine Reports Positive Clinical Trial Results
Feb 09 2026
NASDAQ.COM
Clearmind Reports Positive Safety Results for AUD Drug in Phase I/IIa Trial
Feb 09 2026
Newsfilter
Cannabis Sector Update: Aurora's Strategic Shift Amid Record Medical Sales
Feb 08 2026
Yahoo Finance
Clearmind Regains Nasdaq Compliance with Share Price Above $1
Dec 31 2025
Globenewswire
Clearmind Regains Nasdaq Compliance with Share Price Above $1
Dec 31 2025
Newsfilter
Clearmind Medicine Advances CMND-100 Clinical Trials for Alcohol Use Disorder
Dec 24 2025
Globenewswire
Clearmind Completes Patient Enrollment for Second Cohort of CMND-100 Trial
Dec 16 2025
Newsfilter
Clearmind Publishes Review on MEAI's Potential in Alcohol Use Disorder Treatment
Dec 12 2025
Newsfilter
Clearmind Regains Nasdaq Compliance with $2.5M Stockholders' Equity
Dec 12 2025
Newsfilter
Planet Labs Shares Rise Approximately 16%; Check Out 20 Stocks Making Moves in Premarket Trading
Dec 11 2025
Benzinga
Clearmind Medicine Set to Execute 1-for-40 Reverse Stock Split Next Week
Dec 11 2025
NASDAQ.COM
Show More News
